1.

Forest biotechnology in Sabah ; Biotechnologies forestières au Sabah

2.

Forest biotechnology in Sabah ; Biotechnologies forestières au Sabah

3.

Forest biotechnology in Sabah ; Biotechnologies forestières au Sabah

4.

Forest biotechnology in Sabah ; Biotechnologies forestières au Sabah

1.

Genotype versus phenotype in families with androgen insensitivity syndrome

2.

Genotype versus phenotype in families with androgen insensitivity syndrome

3.

Genotype versus phenotype in families with androgen insensitivity syndrome

4.

Genotype versus phenotype in families with androgen insensitivity syndrome

1.

A genome-wide search for linkage-disequilibrium with type 1 diabetes in a recent genetically isolated population from the Netherlands

2.

A genome-wide search for linkage-disequilibrium with type 1 diabetes in a recent genetically isolated population from the Netherlands

3.

A genome-wide search for linkage-disequilibrium with type 1 diabetes in a recent genetically isolated population from the Netherlands

4.

A genome-wide search for linkage-disequilibrium with type 1 diabetes in a recent genetically isolated population from the Netherlands

1.

Association between an insulin-like growth factor I gene promoter polymorphism and bone mineral density in the elderly: the Rotterdam Study

2.

Association between an insulin-like growth factor I gene promoter polymorphism and bone mineral density in the elderly: the Rotterdam Study

3.

Association between an insulin-like growth factor I gene promoter polymorphism and bone mineral density in the elderly: the Rotterdam Study

4.

Association between an insulin-like growth factor I gene promoter polymorphism and bone mineral density in the elderly: the Rotterdam Study

1.

Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis

2.

Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis

3.

Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis

4.

Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis

1.

Dihydrofolate-Reductase Mutations in Plasmodium knowlesi Appear Unrelated to Selective Drug Pressure from Putative Human-To-Human Transmission in Sabah, Malaysia ... : تظهر طفرات د...

1.

Unraveling the genetic diversity of Belgian Milk Sheep using medium-density SNP genotypes.

2.

Unraveling the genetic diversity of Belgian Milk Sheep using medium-density SNP genotypes.

3.

Unraveling the genetic diversity of Belgian Milk Sheep using medium-density SNP genotypes.

4.

Unraveling the genetic diversity of Belgian Milk Sheep using medium-density SNP genotypes.

5.

Unraveling the genetic diversity of Belgian Milk Sheep using medium-density SNP genotypes.

6.

Unraveling the genetic diversity of Belgian Milk Sheep using medium-density SNP genotypes.

7.

Unraveling the genetic diversity of Belgian Milk Sheep using medium-density SNP genotypes.

8.

Unraveling the genetic diversity of Belgian Milk Sheep using medium-density SNP genotypes.

9.

Unraveling the genetic diversity of Belgian Milk Sheep using medium-density SNP genotypes.

1.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

2.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

3.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

4.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

5.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

6.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

7.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

8.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

9.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.

1.

Genetic Screening of LCA in Belgium: Predominance of CEP290 and Identification of Potential Modifier Alleles in AHI1 of CEP290-Related Phenotypes

2.

Genetic Screening of LCA in Belgium: Predominance of CEP290 and Identification of Potential Modifier Alleles in AHI1 of CEP290-Related Phenotypes

3.

Genetic Screening of LCA in Belgium: Predominance of CEP290 and Identification of Potential Modifier Alleles in AHI1 of CEP290-Related Phenotypes

4.

Genetic Screening of LCA in Belgium: Predominance of CEP290 and Identification of Potential Modifier Alleles in AHI1 of CEP290-Related Phenotypes

5.

Genetic Screening of LCA in Belgium: Predominance of CEP290 and Identification of Potential Modifier Alleles in AHI1 of CEP290-Related Phenotypes

6.

Genetic Screening of LCA in Belgium: Predominance of CEP290 and Identification of Potential Modifier Alleles in AHI1 of CEP290-Related Phenotypes

7.

Genetic Screening of LCA in Belgium: Predominance of CEP290 and Identification of Potential Modifier Alleles in AHI1 of CEP290-Related Phenotypes

8.

Genetic Screening of LCA in Belgium: Predominance of CEP290 and Identification of Potential Modifier Alleles in AHI1 of CEP290-Related Phenotypes

9.

Genetic Screening of LCA in Belgium: Predominance of CEP290 and Identification of Potential Modifier Alleles in AHI1 of CEP290-Related Phenotypes

1.

The association between lower educational attainment and depression owing to shared genetic effects? Results in ~25,000 subjects.

2.

The association between lower educational attainment and depression owing to shared genetic effects? Results in ~25,000 subjects.

3.

The association between lower educational attainment and depression owing to shared genetic effects? Results in ~25,000 subjects.

4.

The association between lower educational attainment and depression owing to shared genetic effects? Results in ~25,000 subjects.